Nu Skin Enterprises, Inc.  

(Public, NYSE:NUS)   Watch this stock  
Find more results for NUS
49.67
+0.19 (0.38%)
Aug 2 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 48.24 - 50.21
52 week 35.44 - 62.01
Open 49.35
Vol / Avg. 816,138.00/1.08M
Mkt cap 3.13B
P/E 17.30
Div/yield 0.20/1.61
EPS 2.87
Shares 63.11M
Beta 1.25
Inst. own 85%
Jul 26, 2012
Q2 2012 Nu Skin Enterprises Earnings Conference Call - Webcast
Jun 26, 2012
Nu Skin Enterprises at Oppenheimer Holdings Inc Consumer Conference - Webcast
May 23, 2012
Nu Skin Enterprises at Citi Global Consumer Conference - Webcast
May 21, 2012
Nu Skin Enterprises Annual Shareholder Meeting
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin 10.35% 8.79%
Operating margin 15.51% 13.40%
EBITD margin - 15.28%
Return on average assets 19.00% 16.28%
Return on average equity 32.09% 29.33%
Employees 3,420 -
Carbon Disclosure Rating - -

Address

75 West Center Street
PROVO, UT 84601
United States - Map
+1-801-3451000 (Phone)
+1-801-3455999 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Nu Skin Enterprises, Inc. is a global direct selling company with operations in 52 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively. The Company operates through a direct selling model with independent distributors in all of its markets except Mainland China. As of December 31, 2011, the Company had more than 850,000 distributors. The Company has two primary product categories, each operating under its own brand. It markets its personal care products under the Nu Skin brand and its nutritional supplements under the Pharmanex brand. During the year ended December 31, 2011, approximately 88% of its revenues came from its markets outside of the United States. On December 13, 2011, the Company acquired LifeGen Technologies, LLC (LifeGen).

Officers and directors

Blake M. Roney Chairman of the Board
Age: 53
Bio & Compensation - Reuters
M. Truman Hunt President, Chief Executive Officer, Director
Portrait. Age: 53
Bio & Compensation - Reuters
Steven J. Lund Vice Chairman of the Board
Age: 58
Bio & Compensation - Reuters
Ritch N. Wood Chief Financial Officer
Age: 46
Bio & Compensation - Reuters
Daniel R. Chard President - Global Sales and Operations
Age: 47
Bio & Compensation - Reuters
Scott E. Schwerdt President, Americas Region
Age: 54
Bio & Compensation - Reuters
Joseph Y. Chang Ph.D. Executive Vice President - Product Development, Chief Scientific Officer
Age: 59
Bio & Compensation - Reuters
D. Matthew Dorny General Counsel, Secretary
Portrait. Age: 47
Bio & Compensation - Reuters
Daniel W. Campbell Lead Independent Director
Age: 57
Bio & Compensation - Reuters
Nevin N. Andersen Independent Director
Age: 71
Bio & Compensation - Reuters